USA investigates flu vaccine crisis
The UK Medicines and Healthcare products Regulatory Agency (MHRA) suspended the plant's manufacturing licence for a period of three months because there was bacterial contamination in the production process.
Chiron Corporation has received a subpoena from the US Attorney's Office, New York. The Attorney's Office requested documents related to Fluvirin, Chiron's flu vaccine. It also wants information regarding the suspension of the licence by the MHRA.
The USA has two main suppliers of flu vaccines for nearly 100% of its doses, Chiron Corporation and Sanofi-Aventis.
Health officials in the USA have asked healthy people to make way for priority cases such as the elderly, diabetics, asthmatics and people with weakened immune systems.
GlaxoSmithkline has expressed an interest in selling its flu vaccine to the US and has entered talks with authorities.
Americans are asking how it is that the FDA let things get this far while the British authorities took action much earlier. Chiron says the FDA knew about an impending problem on September 13th, the UK authorities say the same - the FDA denies it knew anything until last week when the UK authorities pulled Chiron's licence.
SUA investigheazã criza gripei vaccin - USA investigates flu vaccine crisis - articole medicale engleza - startsanatate